【摘 要】
：
Context and Objective:Thiazolidinediones (TZDs) inhibit estrogen production in ovarian cells.We explored whether TZDs affect aromatase activity.Materials & Methods:Human granulosa cells were incubated
【机 构】
：
Endocrinology & Metabolism Laboratory USA
【出 处】
：
中国上海第七届国际新药发明科技年会
论文部分内容阅读
Context and Objective:Thiazolidinediones (TZDs) inhibit estrogen production in ovarian cells.We explored whether TZDs affect aromatase activity.Materials & Methods:Human granulosa cells were incubated in culture medium supplemented with 3 μ M of androstenedione or testosterone,with or without insulin,TZDs (25-50 μ M),type 1 aromatase inhibitor (AI) (100-200 nM) or 17-hydroxysteroid-dehydrogenase (17-HSD) inhibitor type 1 or type 2 (1-5 μM).Estrogen concentration in medium,aromatase mRNA and protein expression,and substrate binding to aromatase were measured.Results:With androstenedione as substrate,estrone production was inhibited by TZDs by 22% (p<0.012).AI abolished inhibitory effect of TZDs on estrogen production,while Type 1 17-HSD inhibitor enhanced rosiglitazone or pioglitazone inhibition of estrone production by 37% (p<0.001) and 67% (p<0.001),respectively.With testosterone as substrate,estradiol production was inhibited by TZDs by 34% (p<0.001).AI reduced inhibitory effect of TZDs on estradiol production by 62% (p<0.001),while Type 2 17-HSD inhibitor (which inhibits both type 2 17-HSD and aromatase activity) abolished inhibitory effects of TZDs on estradiol production.
其他文献
Molecular targets for anti-cancer drugs have emerged from the accumulated evidence obtained by a huge number of the studies in oncology during more than recent three decades.These molecular-targeted a
Cancer is a complex disease resulting from perturbations in multiple regulatory intracellular systems leading to an overall increase in cell number and thus tumor formation.As cancer is a multifactori
Disordered lipid metabolism is always closely linked to inflammation.However,mechanisms of coordinate regulation of lipid metabolism and inflammation are unknown.Oxygenated cholesterols,oxysterols,app
In addition to P-glycoprotein/ABCB 1,for which third-generation inhibitors are in clinical development,two more-recently discovered ABC (ATP-binding cassette) transporters are critically involved in t
1.Nutritional concepts for treatment of chronic inflammatory diseases.Inflammation is defined as one of the first responses of the immune system to injury.When the injury is not eliminated,resolution
Multi-drug resistant (MDR) bacteria present a significant,global healthcare problem that is amplified by the lack of new antibiotics,especially against MDR gram-negative pathogens.We developed new pha
Tuberculosis is today amongst the worldwide health threats.As resistant strains of Mycobacterium tuberculosis have slowly emerged,treatment failure is too often a fact.Discovery of new efficient drug
Bimodal relapse patterns have now been identified in 13 independent breast cancer databases from the US,Europe and Asia.As my colleagues and I have reported,interpretation of this pattern strongly sug
Objectives:Anticancer therapies with vascular disrupting agents (VDAs) or radiofrequency ablation (RFA) can noninvasively or minimum-invasively induce tumor necrosis but often leave viable residues le
Diabetes mellitus is a chronic disease which is estimated to affect more than 171 million people worldwide.Despite the recent clinical success of GLP-1 and DPP4-based treatments,the unmet medical need